RIVRESSO Trademark

Trademark Overview

On Wednesday, April 1, 2020, a trademark application was filed for RIVRESSO with the United States Patent and Trademark Office. The USPTO has given the RIVRESSO trademark a serial number of 88855876. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 11, 2023. This trademark is owned by Pfizer Inc.. The RIVRESSO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of Alopecia Areata, Vitiligo, irritable bowel disease, ulcerative colitis and chron's disease; pharmaceutical preparations for the treatment of autoimmune and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of skin disorders; medicated dermatological preparations
rivresso

General Information

Serial Number88855876
Word MarkRIVRESSO
Filing DateWednesday, April 1, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 11, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 16, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of Alopecia Areata, Vitiligo, irritable bowel disease, ulcerative colitis and chron's disease; pharmaceutical preparations for the treatment of autoimmune and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of skin disorders; medicated dermatological preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 9, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, September 11, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 11, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, March 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, January 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 19, 2023SOU EXTENSION 5 GRANTED
Wednesday, January 4, 2023SOU EXTENSION 5 FILED
Thursday, January 19, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 4, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, July 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 18, 2022SOU EXTENSION 4 GRANTED
Monday, July 18, 2022SOU EXTENSION 4 FILED
Monday, July 18, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, January 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 10, 2022SOU EXTENSION 3 GRANTED
Monday, January 10, 2022SOU EXTENSION 3 FILED
Monday, January 10, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, July 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 12, 2021SOU EXTENSION 2 GRANTED
Monday, July 12, 2021SOU EXTENSION 2 FILED
Monday, July 12, 2021SOU TEAS EXTENSION RECEIVED
Saturday, January 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 21, 2021SOU EXTENSION 1 GRANTED
Thursday, January 21, 2021SOU EXTENSION 1 FILED
Thursday, January 21, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, August 11, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 16, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 16, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 27, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 14, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 14, 2020ASSIGNED TO EXAMINER
Thursday, April 9, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 4, 2020NEW APPLICATION ENTERED

Related Keywords

rivresso preparations pharmaceutical treatment disease disorders inflammatory diseases skin dermatological medicated